Hongjin Shi

Kunming Medical University

Papers

1

Total Citations

13

H-Index

1

About

Hongjin Shi is a leading researcher in urologic oncology, with a primary focus on advancing surgical techniques for bladder cancer treatment. His work centers on evaluating and optimizing robot-assisted radical cystectomy (RARC), particularly when combined with intracorporeal urinary diversion (iRARC). In his highly cited 2024 systematic review and meta-analysis, Shi provided a critical, updated comparison of iRARC versus open radical cystectomy (ORC), addressing the ongoing controversy over which approach offers superior perioperative outcomes and safety. By synthesizing evidence from multiple studies, his research has helped clarify the differential effects of these complex procedures, guiding surgeons in evidence-based decision-making. This work, already garnering 13 citations shortly after publication, underscores his role in shaping modern urologic practice. Shi’s contributions are vital for clinicians seeking to reduce complications and improve recovery for patients undergoing radical cystectomy, making him a notable voice in the field of minimally invasive urologic surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
13
Total Citations
13
Avg Citations/Paper
🏆 Most Cited Paper
Robot-assisted radical cystectomy with intracorporeal urinary diversion: an updated systematic review and meta-analysis of its differential effect on effectiveness and safety
13 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Kunming Medical University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago